"Mercy Fitzgerald is a 204-bed teaching hospital located in Darby, Pa., offering advanced acute care services in Delaware County and Southwest Philadelphia. Built in part thanks to property willed by local philanthropist Thomas M. Fitzgerald, the hospital opened on July 1, 1933. During its 85-year history, the hospital has been recognized for innovative milestones in the field of medicine and patient care. It was the first to introduce a hospital-administered Home Care Program in 1969 and one of the first to provide paramedic services in the early 1980s. More recently, the hospital was the first in the County to install a 64-Slice CT scanner."

During the past decade, Mercy Fitzgerald Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 24 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Fitzgerald Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 46 trials, followed by "National Cancer Institute (NCI)" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Fitzgerald Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "North Central Cancer Treatment Group" with 8 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Fitzgerald Hospital" are "Prostate Cancer" (12 trials), "Head and Neck Cancer" (10 trials), "Lung Cancer" (8 trials), "Breast Cancer" (5 trials) and "Metastatic Cancer" (5 trials). Many other conditions were trialed in "Mercy Fitzgerald Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Fitzgerald Hospital" are "Drug" (58 trials), "Radiation" (46 trials), "Biological" (21 trials), "Procedure" (20 trials) and "Other" (16 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (33 trials), "cisplatin" (12 trials), "paclitaxel" (11 trials), "Laboratory Biomarker Analysis" (10 trials) and "conventional surgery" (10 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Fitzgerald Hospital" are 54 trials for "All" genders, 11 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Fitzgerald Hospital". undefined are not yet recruiting, 1 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Mercy Fitzgerald Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Fitzgerald Hospital, 9 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Mercy Fitzgerald Hospital has several departments that took part in Clinical trials: "Saint Mary Medical and Regional Cancer Center" - 26 trials, "Javed Rheumatology Associates, Inc." - 14 trials